Archana Bhogill, MD
Family Practice · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 3 carriers
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bhogill’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
9 of 9 plans
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C54134 · Current
Licensed to practise in California · since 2010 · expires 2027-07-31 · Mangalore University, Kasturba Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Illinois 036112814Licensed Physician And Surgeon · since 2004 · expires 2011-07-31InactiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$1,022
Medicare paid this office $1,022 for 13 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
13 Original Medicare patients in 2024. Average age 78 · Under 65 0% · Health risk score 1.21. Above the middle of the specialty; the typical family practice clinician is at 1.13.
The office billed $6,326, Medicare allowed $1,860 and paid $1,022; for 22 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 13 | 22 | 78 | 1.21 | $6,326 | $1,022 |
| 2022 | 33 | 41 | 75 | 0.81 | $13,910 | $2,964 |
| 2019 | 97 | 210 | 74 | 1.21 | $28,963 | $10,345 |
| 2018 | 191 | 422 | 73 | 0.94 | $56,134 | $25,135 |
| 2017 | 43 | 89 | 71 | 0.82 | $10,613 | $5,247 |
| 2014 | 111 | 166 | 75 | 1.14 | $31,756 | $7,661 |
| 2013 | 207 | 404 | 73 | 0.95 | $65,171 | $18,079 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 2 services
| New patient visit (30+ min) | 19 | $1,965 | $103 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 12 | $605 | $50 |
2019: 3 services
| Return visit (30+ min) | 69 | $6,546 | $80 |
| New patient visit (45+ min) | 17 | $1,465 | $86 |
| Automated urinalysis test | 16 | $39 | $2 |
2018: 5 services
| Return visit (30+ min) | 130 | $15,149 | $89 |
| New patient visit (45+ min) | 34 | $4,468 | $131 |
| New patient visit (30+ min) | 22 | $2,027 | $92 |
| Injection of drug or substance under skin or into muscle | 15 | $290 | $16 |
| Automated urinalysis test | 14 | $41 | $3 |
2017: 2 services
| Return visit (30+ min) | 23 | $2,030 | $78 |
| Short return visit (20+ min) | 18 | $1,324 | $51 |
2014: 4 services
| Short return visit (20+ min) | 57 | $3,297 | $56 |
| Return visit (30+ min) | 27 | $1,726 | $62 |
| New patient visit (15+ min) | 23 | $1,242 | $54 |
| Urinalysis, manual test | 11 | $38 | $3 |
2013: 7 services
| Return visit (30+ min) | 75 | $6,305 | $76 |
| Short return visit (20+ min) | 72 | $4,182 | $51 |
| New patient visit (15+ min) | 48 | $2,529 | $53 |
| New patient visit (30+ min) | 13 | $951 | $73 |
| X-ray of chest, 2 views, front and side | 21 | $478 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $199 | $17 |
| Urinalysis, manual test | 14 | $52 | $3 |
Medicaid work
$1,225,324 in 2024
Medicaid paid $1,225,324 for 15,553 billed services this clinician did in 2024, up to 255 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,883 | $1,194,080 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 39 | $22,848 |
| Short return visit (20+ min) | 3,064 | $5,174 |
| New patient visit (30+ min) | 397 | $2,895 |
| Short return visit | 165 | $142 |
| Return visit (30+ min) | 19 | $137 |
| URINE PREGNANCY TEST | 219 | $44 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 143 | $4 |
| Pain severity quantified; pain present (COA) (ONC) | 484 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 393 | $0 |
| Medication list documented in medical record (COA) | 2,042 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 2,021 | $0 |
| 2024 | 15,553 | 17 | 255 | $1,225,324 |
| 2023 | 9,649 | 12 | 247 | $1,353,679 |
| 2022 | 9,369 | 12 | 274 | $1,144,429 |
| 2021 | 7,398 | 10 | 205 | $1,056,069 |
| 2020 | 3,963 | 5 | 205 | $354,021 |
| 2019 | 2,164 | 7 | 148 | $197,855 |
| 2018 | 726 | 3 | 40 | $42,656 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 2,192 | $1,339,862 |
| Short return visit (20+ min) | 3,773 | $11,710 |
| New patient visit (30+ min) | 260 | $2,010 |
| URINE PREGNANCY TEST | 173 | $88 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 113 | $9 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 161 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 966 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 234 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 286 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 861 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 486 | $0 |
| Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM) | 144 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,901 | $1,130,643 |
| Short return visit (20+ min) | 3,689 | $13,642 |
| Short return visit | 27 | $77 |
| URINE PREGNANCY TEST | 79 | $60 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 74 | $6 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 113 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 1,151 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 313 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 295 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 1,148 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 479 | $0 |
| Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM) | 100 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 1,994 | $1,047,347 |
| Short return visit (20+ min) | 3,347 | $8,719 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 49 | $3 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 156 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 628 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 146 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 157 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 683 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 177 | $0 |
| Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM) | 61 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 1,513 | $348,611 |
| Short return visit (20+ min) | 2,340 | $5,355 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 18 | $50 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 68 | $5 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 24 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 663 | $173,076 |
| Return visit (30+ min) | 130 | $11,610 |
| Supplies and materials (except spectacles), provided by the physician or other qualified health care professional over and above those usually included with the office visit or other services rendered (list drugs, trays, supplies, or materials provided) | 173 | $6,228 |
| Short return visit (20+ min) | 1,131 | $4,343 |
| New patient visit (45+ min) | 24 | $2,160 |
| New patient visit (30+ min) | 22 | $439 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 21 | $0 |
2018
| Return visit (30+ min) | 304 | $27,020 |
| Supplies and materials (except spectacles), provided by the physician or other qualified health care professional over and above those usually included with the office visit or other services rendered (list drugs, trays, supplies, or materials provided) | 410 | $14,616 |
| New patient visit (45+ min) | 12 | $1,020 |
Drugs they prescribed that Part D paid
$2,077
Pharmacies billed $2,077 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 191) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
168 generic and 23 brand-name prescriptions · $2,077 in drug cost · 53 antibiotic prescriptions to 50 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Albuterol Sulfate Hfa | 13 | $364 | $28 |
| Amoxicillin-Clavulanate Potass | 12 | $70 | $6 |
| Cephalexin | 19 | $59 | $3 |
Year by year
| 2024 | 191 | 131 | 0% (0) | 12% | $2,077 |
| 2023 | 152 | 114 | 0% (0) | 8% | $3,784 |
| 2022 | 214 | 161 | 0% (0) | None | $4,654 |
| 2021 | 209 | 146 | 0% (0) | 12% | $5,462 |
| 2020 | 142 | 105 | 0% (0) | 20% | $6,613 |
| 2019 | 203 | 144 | 0% (0) | 16% | $5,204 |
| 2018 | 295 | 176 | None | 12% | $5,801 |
| 2017 | 403 | 133 | None | 10% | $12,222 |
| 2016 | 328 | 90 | 4% (12) | 10% | $10,223 |
| 2015 | 225 | 78 | None | None | $6,672 |
| 2014 | 265 | 121 | 5% (13) | 11% | $7,481 |
| 2013 | 417 | 166 | 7% (30) | None | $16,860 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Cephalexin | 15 | $141 | $9 |
2022: 2 drugs
| Cephalexin | 25 | $137 | $5 |
| Ibuprofen | 16 | $50 | $3 |
2021: 2 drugs
| Cephalexin | 18 | $75 | $4 |
| Ibuprofen | 17 | $63 | $4 |
2020: 2 drugs
| Albuterol Sulfate Hfa | 11 | $621 | $56 |
| Cephalexin | 11 | $50 | $5 |
2019: 2 drugs
| Nitrofurantoin Mono-Macro | 14 | $335 | $24 |
| Amoxicillin-Clavulanate Potass | 20 | $242 | $12 |
2018: 8 drugs
| Ventolin Hfa | 11 | $604 | $55 |
| Nitrofurantoin Mono-Macro | 12 | $366 | $31 |
| Amoxicillin-Clavulanate Potass | 16 | $168 | $10 |
| Mupirocin | 12 | $131 | $11 |
| Azithromycin | 17 | $111 | $7 |
| Sulfamethoxazole-Trimethoprim | 12 | $64 | $5 |
| Atenolol | 12 | $57 | $5 |
| Metoprolol | 14 | $47 | $3 |
2017: 7 drugs
| Levothyroxine | 25 | $620 | $25 |
| Atorvastatin | 36 | $540 | $15 |
| Omeprazole | 11 | $199 | $18 |
| Amoxicillin-Clavulanate Potass | 15 | $190 | $13 |
| Escitalopram | 20 | $132 | $7 |
| Lisinopril | 15 | $102 | $7 |
| Metoprolol | 26 | $65 | $3 |
2016: 6 drugs
| Levothyroxine | 27 | $653 | $24 |
| Atorvastatin | 29 | $358 | $12 |
| Escitalopram | 25 | $171 | $7 |
| Azithromycin | 12 | $88 | $7 |
| Lisinopril | 14 | $72 | $5 |
| Metoprolol | 20 | $68 | $3 |
2015: 3 drugs
| Levothyroxine | 12 | $355 | $30 |
| Atorvastatin | 26 | $227 | $9 |
| Lisinopril-Hydrochlorothiazide | 11 | $42 | $4 |
2014: 5 drugs
| Atorvastatin | 14 | $277 | $20 |
| Atenolol | 14 | $163 | $12 |
| Azithromycin | 14 | $110 | $8 |
| Hydrocodone-Acetaminophen | 13 | $80 | $6 |
| Cephalexin | 13 | $72 | $6 |
2013: 7 drugs
| Zetia | 12 | $2,242 | $187 |
| Doxycycline Hyclate | 14 | $782 | $56 |
| Azithromycin | 21 | $177 | $8 |
| Lisinopril | 12 | $128 | $11 |
| Hydrocodone-Acetaminophen | 25 | $111 | $4 |
| Ciprofloxacin | 15 | $86 | $6 |
| Cephalexin | 14 | $71 | $5 |
Professional record
- NPI
- 1598723058
- Licence
- CA C54134, IL 36112814California C54134: Current · expires 2027-07-31Illinois 036112814: Inactive
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2006-05-03
- NPI last updated
- 2025-10-22
- NPI record certified
- 2025-10-22
This is when the NPI record was last certified, not a medical board exam.